A new diagnostic imaging technique using lacrimal gland color Doppler ultrasonography could move Sjögren’s syndrome detection earlier, according to researchers behind the approach. The report describes a noninvasive method aimed at capturing signals of autoimmune gland involvement before the disease progresses to commonly recognized clinical thresholds. The technique targets the lacrimal gland, an organ central to Sjögren’s pathology, and is positioned as a way to address diagnostic delay that can complicate management and longitudinal planning. For clinicians and developers, the key industry relevance is the potential for an imaging-based pathway to complement existing serologic and symptom-driven diagnostic criteria, especially where early identification can support earlier intervention. Further validation will be needed to define sensitivity and specificity across patient subgroups, but the concept adds a new tool to the diagnostic portfolio for a chronic autoimmune disease with high burden.